Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...
Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...
New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.
China: A recent study published in the Journal of Stroke and Cerebrovascular Diseases has highlighted the potential of ...
The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...
In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback